Digital Health Tools Need a New Benchmark (and Evidence)

Digital Health Tools Need a New Benchmark (and Evidence)

The good AI and healthtech can do is undisputed, but testing new technology using old methods is holding it back. Currently, only 20% of healthcare companies producing digital health technologies have the necessary scientific evidence to back up the benefits they claim to provide. In the future, regulators and payers (such as insurance companies and healthcare providers) will require more clarity on the evidence for these technologies, leading to increased scrutiny and a consensus on the ways in which this evidence should be generated. 

In the future, clinical simulations and synthetic data (mock data based on real patient data) will become more widely accepted as a way to generate evidence for these technologies, and that programs such as the Early Value Assessment Program for Digital Tools will help clinicians properly evaluate the claims made by digital health companies.

Read on wired.com




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on May 29, 2024 at 11:21am